Assess the proportion of treatment effect explained by a longitudinal surrogate marker as described in Agniel D and Parast L (2021) <doi:10.1111/biom.13310>.
Version: |
1.0 |
Depends: |
R (≥ 3.5.0) |
Imports: |
stringr, splines, mgcv, Rsurrogate, dplyr, here, tidyr, fs, KernSmooth, stats, fdapace, grf, lme4, mvnfast, plyr, tibble, magrittr, glue, purrr, readr, refund, fda, fda.usc |
Published: |
2022-09-29 |
DOI: |
10.32614/CRAN.package.longsurr |
Author: |
Layla Parast [aut, cre],
Denis Agniel [aut] |
Maintainer: |
Layla Parast <parast at austin.utexas.edu> |
License: |
GPL-2 | GPL-3 [expanded from: GPL] |
NeedsCompilation: |
no |
CRAN checks: |
longsurr results |